Company / FCF Margin
CAPRICOR THERAPEUTICS, INC. FCF Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-184.8%
FY2024
5-year range
-7352.3% / 114.3%
FY2020-FY2024
Trend
-72.9%
vs FY2023
Sector context
#97 of 135
Health Care
What the data says
At -184.8%, CAPRICOR THERAPEUTICS, INC.'s fcf margin ranks #97 of 135 in the Health Care sector. Declined from 114.3% to -184.8% over the past 2 years.
Based on SEC 10-K filings.
-184.8% in FY2024 with a 5-year CAGR of +663.5%.
Declined from 114.3% to -184.8% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +7167.5pp
- 5-Year Change
- +663.5pp
- 10-Year Change
- -
Sector benchmark
#97 of 135 in Health CareTop 72% of 135This company -184.8% Sector average -680.1%
▼
+72.8% above sector average
Key checks
Key Insights
- In FY2024, fcf margin decreased 72.9% year-over-year.
- Currently 495.3pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -184.8% | -72.9% |
| FY2023 | -106.9% | -193.5% |
| FY2022 | 114.3% | +101.6% |
| FY2021 | -7352.3% | -115.1% |
| FY2020 | -3417.4% | -302.8% |
| FY2019 | -848.3% | +0.0% |
| FY2018 | -848.3% | -58.6% |
| FY2017 | -534.9% | -46.0% |
| FY2016 | -366.3% | -84.6% |
As of FY2024 · SEC 10-K · Updated Jul 4, 2026